Which pharma company is growing in India?
Table of Contents
Which pharma company is growing in India?
Detailed Overview of the Best Pharma Stocks to Buy
| Company Name | BSE Scrip Code | Compounded Sales Growth (5 years) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 524715 | 3.00% |
| Dr. Reddys Laboratories Ltd. | 500124 | 4.00% |
| Divis Laboratories Ltd. | 532488 | 13.00% |
| Cipla Ltd. | 500087 | 7.00% |
How many pharma companies are there in India in 2021?
The domestic pharmaceutical industry includes a network of 3,000 drug companies and ~10,500 manufacturing units. India enjoys an important position in the global pharmaceuticals sector.
Which is the best pharma stocks to buy now?
7 pharma stocks that may deliver 20-50% returns. Do you own any?
- Pharma Picks.
- Suven: Commercialisation of new molecules on cards.
- Gland Pharma: Biologics, China foray key drivers.
- Dr Reddy’s Labs: Prospects improving.
- Cipla: Earnings sustainable.
- JB Chemicals: Widening wings in India.
Which is the best pharma stock to buy?
Best Pharma Stocks India
- Sun Pharmaceutical Industries.
- Divi’s Laboratories.
- Cipla.
- Dr. Reddy’s Laboratories.
What is the future of Sun Pharma?
The higher strength in a market that normally grows at 10 per cent, is expected to translate into even higher growth for Sun Pharma which focusses on product launches (28 launched in Q2FY22 alone) and in-licensing opportunities. Sun Pharma reported sales growth of 2.5 per cent in FY21 of ₹33,139 crore.
IS Pharma A good investment?
Absolutely. We are seeing stock specific opportunities in the pharma sector.
Should I invest in Sun Pharma?
Sun Pharma stock has rewarded investors with a 47.1 percent return in the past one year, exceeding the Nifty50’s 23.1 percent rise by a wide margin. The brokerage retained its ‘buy’ rating on the Sun Pharma stock with a target price of Rs 1,070.
